CD4+ Cancer Research Results
CD4+, CD4+ T Cells: Click to Expand ⟱
| Source: |
| Type: |
CD4+ T cells are T lymphocytes that express T cell receptors (TCRs).
Majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background.
multifaceted role of CD4+ T cells in the anti-tumour immune response.
CD4+ T cells play a critical role in developing and sustaining effective anti-tumour immunity, even in cancer immunotherapies specifically designed to activate a CD8+ CTL response.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-453 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
| - |
in-vitro, |
BC, |
4T1 |
|
|
|
- |
in-vitro, |
Nor, |
3T3 |
|
|
|
TumCD↑, CD4+↑, ROS↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, TumCD↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, TumCG↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 2, Imm↑, 1, NF-kB↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, OS↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CD4+, CD4+ T Cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:544 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page